Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer-Reference-Cited by-同舟云学术

Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer

Published:2015-08-12 Issue:2 Volume:5 Page:e1075114
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Mall Christine,Sckisel Gail D.,Proia David A.,Mirsoian Annie,Grossenbacher Steven K.,Pai Chien-Chun Steven,Chen Mingyi,Monjazeb Arta M.,Kelly Karen,Blazar Bruce R.,Murphy William J.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1075114

Reference60 articles.

1. Cancer Immunotherapy

2. The blockade of immune checkpoints in cancer immunotherapy

3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

4. Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

5. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting CAR-T cell therapy with CRISPR technology;hLife;2024-08

2. Camrelizumab-induced anaphylactic reaction: a case report and literature review;Journal of Chemotherapy;2024-06-27

3. A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling;Molecular Cancer Therapeutics;2024-04-30

4. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity;Cancer Discovery;2024-03-01

5. Mediation of the JNC/ILC2 pathway in DBP-exacerbated allergic asthma: A molecular toxicological study on neuroimmune positive feedback mechanism;Journal of Hazardous Materials;2024-03